A 62-year-old woman undergoes colonoscopy for iron-deficiency anemia and is found to have a 4 cm mass in the sigmoid colon. Biopsy confirms adenocarcinoma. She is asymptomatic for metastatic disease. Which investigation is most appropriate as the next step to complete preoperative staging?

Explanation

## Investigation of Choice for Distant Staging (M-Staging) of Colorectal Cancer **Key Point:** High-resolution CT of the chest, abdomen, and pelvis is the standard investigation for detecting distant metastases (M-staging) in colorectal cancer and is essential for treatment planning before surgery. ### Role of CT in Colorectal Cancer Staging **High-Yield:** CT chest/abdomen/pelvis is the workhorse for M-staging because it: - Detects hepatic metastases (most common site, ~25% at presentation) - Identifies peritoneal deposits and ascites - Assesses resectability of the primary tumor and local spread - Evaluates pericolic and distant lymph nodes - Screens for pulmonary metastases (chest CT) - Is rapid, reproducible, and widely available **Clinical Pearl:** In colorectal cancer, the liver is the most frequent site of metastatic spread. CT has sensitivity ~85–95% for detecting hepatic lesions >1 cm. Unresectable metastases (e.g., bilobar liver disease, extrahepatic metastases) may preclude curative surgery. ### Staging Sequence in Colorectal Cancer ```mermaid flowchart TD A[Colorectal cancer confirmed on colonoscopy + biopsy]:::outcome --> B[Step 1: Local staging]:::action B --> C[ERUS for rectal cancer OR CT for colon cancer]:::action C --> D[Determine T and N stage]:::outcome A --> E[Step 2: Distant staging]:::action E --> F[CT chest/abdomen/pelvis]:::action F --> G{Metastases present?}:::decision G -->|No M1| H[Proceed to curative surgery]:::action G -->|M1 resectable| I[Consider metastasectomy + chemotherapy]:::action G -->|M1 unresectable| J[Palliative chemotherapy]:::action ``` ### Comparison of Distant Staging Investigations | Investigation | Sensitivity for Metastases | Advantages | Disadvantages | Role | |---|---|---|---|---| | **CT chest/abdomen/pelvis** | ~85–95% for liver; ~90% for lung | Gold standard; detects liver, lung, peritoneal disease; rapid; reproducible | Misses small lesions <1 cm; radiation exposure | **First-line for M-staging** | | **PET-CT** | ~70–80% for metastases | High specificity; detects unsuspected distant metastases; useful for high-risk patients | Expensive; lower sensitivity for small lesions; not routine for all patients | Recurrent/metastatic disease; high-risk cases | | **Diagnostic laparoscopy** | ~90% for peritoneal disease | Detects occult peritoneal metastases missed by CT | Invasive; requires anesthesia; not routine | Selected cases (suspected peritoneal disease) | | **Transabdominal ultrasound** | ~70% for liver | Non-invasive; no radiation | Operator-dependent; limited field; poor for lung staging | Not recommended for staging | **Mnemonic:** **CT for Colon, ERUS for Rectum** — CT is the standard for distant staging in all colorectal cancers; ERUS is added for rectal cancers to assess local invasion. ### When to Use PET-CT vs. CT **Key Point:** PET-CT is **not** routine for initial staging of colorectal cancer. It is reserved for: - Suspected recurrent disease - High-risk patients (elevated CEA, imaging findings suggestive of metastases) - Equivocal CT findings - Staging of metastatic disease For initial staging in an asymptomatic patient with a localized tumor, **CT is the standard**.